Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy

被引:29
作者
Suzuki, Y [1 ]
Isogai, K
Teramoto, T
Tashita, H
Shimozawa, N
Nishimura, M
Asano, T
Oda, M
Kamei, A
Ishiguro, H
Kato, S
Ohashi, T
Kobayashi, H
Eto, Y
Kondo, N
机构
[1] Gifu Univ, Sch Med, Dept Pediat, Gifu 5008705, Japan
[2] Natl Sanatorium Nagara Hosp, Dept Pediat, Gifu, Japan
[3] Okayama Univ, Sch Med, Dept Child Neurol, Okayama, Japan
[4] Okayama Univ, Sch Med, Dept Pediat, Okayama, Japan
[5] Iwate Med Univ, Dept Pediat, Morioka, Iwate, Japan
[6] Tokai Univ, Sch Med, Dept Pediat, Isehara, Kanagawa 25911, Japan
[7] Jikei Univ, Dept Pediat, Tokyo, Japan
[8] Jikei Univ, Inst DNA Med, Tokyo, Japan
关键词
D O I
10.1023/A:1005656029200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of bone marrow transplantation (BMT) in X-linked childhood adrenoleukodystrophy (ALD) are described in four Japanese patients. Two older patients, 10-year-old boys with IQ 60 and difficulty in school, had favourable results. IQ levels and MRI findings were generally maintained after BMT. One patient showed improvement of gait disturbance. They have both attended ordinary schools after BMT, although a learning disorder persists. On the other hand, two other younger patients with a rapid course and indeterminate IQ at BMT showed deterioration of neurological functions. Indication for BMT seems to be a maintained IQ level, preferably higher than 80, since it seems to be difficult to normalize IQ level after BMT. Younger patients have higher risk of developing a rapidly progressive form of the disease. Identification of presymptomatic boys, and serial and careful follow-up by neuropsychological and neuroradiological studies, are essential prerequisites to successful BMT in X-ALD.
引用
收藏
页码:453 / 458
页数:6
相关论文
共 17 条
[1]   A 2-YEAR TRIAL OF OLEIC AND ERUCIC ACIDS (LORENZO OIL) AS TREATMENT FOR ADRENOMYELONEUROPATHY [J].
AUBOURG, P ;
ADAMSBAUM, C ;
LAVALLARDROUSSEAU, MC ;
ROCCHICCIOLI, F ;
CARTIER, N ;
JAMBAQUE, I ;
JAKOBEZAK, C ;
LEMAITRE, A ;
BOUREAU, F ;
WOLF, C ;
BOUGNERES, PF .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (11) :745-752
[2]   REVERSAL OF EARLY NEUROLOGIC AND NEURORADIOLOGICAL MANIFESTATIONS OF X-LINKED ADRENOLEUKODYSTROPHY BY BONE-MARROW TRANSPLANTATION [J].
AUBOURG, P ;
BLANCHE, S ;
JAMBAQUE, I ;
ROCCHICCIOLI, F ;
KALIFA, G ;
NAUDSAUDREAU, C ;
ROLLAND, MO ;
DEBRE, M ;
CHAUSSAIN, JL ;
GRISCELLI, C ;
FISCHER, A ;
BOUGNERES, PF .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (26) :1860-1866
[3]  
Inagaki Masumi, 1995, Acta Paediatrica Japonica, V37, P125
[4]   THE FUTURE FOR TREATMENT BY BONE-MARROW TRANSPLANTATION FOR ADRENOLEUKODYSTROPHY, METACHROMATIC LEUKODYSTROPHY, GLOBOID-CELL LEUKODYSTROPHY AND HURLER-SYNDROME [J].
KRIVIT, W ;
LOCKMAN, LA ;
WATKINS, PA ;
HIRSCH, J ;
SHAPIRO, EG .
JOURNAL OF INHERITED METABOLIC DISEASE, 1995, 18 (04) :398-412
[5]  
LOES DJ, 1994, AM J NEURORADIOL, V15, P1761
[6]  
LOES DJ, 1994, AM J NEURORADIOL, V15, P1767
[7]   Treatment of adrenoleukodystrophy with bone marrow transplantation [J].
Malm, G ;
Ringden, O ;
Anvret, M ;
vonDobeln, U ;
Hagenfeldt, L ;
Isberg, B ;
Knuutila, S ;
Nennesmo, I ;
Winiarski, J ;
Marcus, C .
ACTA PAEDIATRICA, 1997, 86 (05) :484-492
[8]  
Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO
[9]  
2-U
[10]   ADRENOLEUKODYSTROPHY - PHENOTYPIC VARIABILITY AND IMPLICATIONS FOR THERAPY [J].
MOSER, HW ;
MOSER, AB ;
SMITH, KD ;
BERGIN, A ;
BOREL, J ;
SHANKROFF, J ;
STINE, OC ;
MERETTE, C ;
OTT, J ;
KRIVIT, W ;
SHAPIRO, E .
JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (04) :645-664